Sema Yılmaz was born on July 30, 1965. She received her undergraduate degree from Istanbul University Cerrahpaşa Medical Faculty and completed her medical residency training at the Department of Pediatrics at Zeynep Kamil Women's and Children's Health and Diseases Hospital. She also completed her medical subspecialty training in Pediatric Hematology/Oncology at Cukurova University. Her medical residency thesis was titled "The Relationship Between Morning First Urine Density and Nocturnal Enuresis in Children Aged 3-6 Years", and her medical subspecialty thesis was titled "Comparison of Sphingosine 1-phosphate Receptor 4 Gene Expression in Healthy Children and Neuroblastoma Patients". She started her medical career as a general practitioner. After working as a general practitioner for 4 years, she worked as a doctor researcher at Zeynep Kamil Women's and Children's Health and Diseases Training and Research Hospital for 5 years. She then served as a specialist doctor, assistant professor, and associate professor at various institutions. She worked at Houston MD Anderson, North Carolina-UNC, Boston-Harvard University in the USA. Additionally, she conducted research on cell therapies. She received the title of professor in Pediatric Hematology/Oncology at Usak Medical Faculty. She is a member of the Turkish Pediatric Oncology Group, European Association for Cancer Research (EACR), Turkish Medical Association, Turkish National Pediatrics Association, Turkish Pediatrics Association, Pediatrics Specialty Academy Association (PUADER), Turkish Immunology Association, Turkish Hematology Association, and Molecular Oncology Association (MOKAD). She currently serves her patients at Koru Hospital. Her medical interests include:

Cell therapies in childhood cancers

Cancer immunology

Investigation of genetic pathways responsible for cancer and metastasis

Pulmonary microbiota

BAL transplantation

1982 - 1988 Istanbul University Cerrahpasa Faculty of Medicine
1992 - 1997 Ministry of Health Zeynep Kamil Gynecology and Pediatrics Training and Research Hospital
             Specialization in Medicine: Child Health and Diseases

2008 - 2012 Çukurova University Faculty of Medicine
             Minor Specialization in Medicine: Pediatric Hematology and Oncology

2008 - 2012 Çukurova University Faculty of Medicine
             Minor Specialization in Medicine: Pediatric Hematology and Oncology

2008 - 2012 Çukurova University Faculty of Medicine
             Minor Specialization in Medicine: Pediatric Hematology and Oncology

MD Anderson Cancer Center, Houston,Tx, USA
Pediatric Oncology
01.07.1996 - 31.08.1996

University of Texas, Hermann Hospital, Tx, USA
Pediatric Nephrology
31.08.1996 - 30.09.1996

University of North Carolina, Chapel Hill, USA
Pediatric Nephrology
01.10.2001 - 31.03.2002

John Hopkin's Children's Hospital, Baltimore, USA
Pediatric Hematology And Oncology
01.07.2010 - 30.07.2010

Istituto Giannina Gaslini, Italy
Department of Paediatric Haematology and Oncology
Bone Marrow Transplantation Unit

Harvard Medical School, USA
Harvard Cancer Biology and Therapeutics Program
09.2016 - 09.2017

Babeş-Bolyai University, Romania
Department of Biology.Electron microscopy center
06.21.2021 - 06.27.2021

Wurzburg University, Germany
Department of Bioinformatics
06.24.2022 - 06.28.2022

Investigation of genetic pathways responsible for cancer and its metastasis
Targeted therapies in childhood cancers
Bleeding diathesis and thrombosis
Molecular investigation of hemoglobinopathies
Cell therapies in childhood cancers

Turkish Pediatric Oncology Group (TPOG)
European Association for Cancer Research (EACR)
Turkish Medical Association (TTB)
Turkish National Pediatric Association (TMPD)
Turkish Pediatrics Institution (TPK)
Pediatrics Specialization Academy Association (PUADER)
Turkish Immunology Association (TİD)
Turkish Society of Hematology (THD)
Molecular Oncology Society (MOKAD)

Articles published in international peer-reviewed journals:

1. M. Ferris, S.L. Hogan, H. Chin, D.A. Shoham, D.S. Gipson, K. Gibson, S. Yilmaz, R.J. Falk, J. C. . Jennet. Obesity, albuminuria, and urinalysis findings in US young adults from the Add Health Wave III study. Clin J Am Soc Nephrol 2007 2(6):1207-1214. Epub 2007 Oct 17.

2. N. Keskin, S. Yilmaz. Pregnancy and tuberculosis: to assess tuberculosis cases in pregnancy in a developing region retrospectively and two case reports. Arch Gynecol Obstet 2008; 278(5): 451-455.

3. C. Akdemir, S. Yilmaz. Sensitization to house dust mite fauna in selected children's homes in Kutahya, Turkey. Turk J Pediatr 2009; 51(3):232-237.

4. I. Bayram, F. Erbey, D. Alabaz, S. Yilmaz, A. Tanyeli. Cefoperazone-sulbactam plus amikacin empirical therapy for febrile neutropenia in children with cancer. Turk J med Sci 2009; 39(1):1-7.

5. I. Bayram F. Erbey, S. Erdem, D. Yildizdas, S. Yilmaz, D. Alabaz, H. Yildizdas, Y. Kılınc, A. Tanyeli. Recombinant Factor VIIa and Activated Prothrombin-Complex Concentrate Administration in the Management of Bleeding, Coagulopathy and Intractable Coagulopathy in Pediatric Patients Undergoing Invasive Medical Procedures or Surgery. Int J Hemato Oncology 2009; 4(19):205-212.

6. F. Erbey, H. Solgun, I. Bayram, E. Akgul, S. Yilmaz, I. Tuncer, A. Tanyeli. Infantile Intracranial Hemangiopericytoma: Case Report. Int J Hemato Oncology 2009; 3(19): 175-179.

7. F. Erbey, I. Bayram, S. Yilmaz, A. Tanyeli. Meropenem monotherapy as an empirical treatment of febrile neutropenia in childhood cancer patients. Asian Pac J Cancer Prev. 2010; 11(1):123-126.

8. B.H. Karabacak, F. Erbey, I. Bayram, S. Yilmaz, C. Acipayam, Y. Kilinç, A. Tanyeli. Fms-like tyrosine kinase 3 mutations in childhood acute leukemias and their association with prognosis. Asian Pac J Cancer Prev. 2010;11(4): 923-927.

9. E. Soyucen, S. Yilmaz, C. Celtik, U. Vatansever, N. Oner, S. Karasalihoglu. Seroprevalence of autoimmune thyroiditis and celiac disease in children with insulin-dependent diabetes mellitus in the Thrace region of Turkey. Turk J Gastroenterol. 2010; 21(3): 231-235.

10. F. Erbey, I. Bayram, S. Yilmaz, A. Tanyeli. The Overview of Diagnostic Criteria and Treatment Options of Transplantation Associated Thrombotic Microangiopathy with Two Case Reports. Int J Hemato Oncology. 2010; 20 (2): 110-114.

11. Erbey F, Bayram I, Kuskonmaz B, Yilmaz S, Cetin M, Uckan D, Tanyeli A. Thrombotic microangiopathy in allogeneic stem cell transplantation in childhood. Exp Clin Transplant. 2010; 8(3): 237-244.

12. S. Yilmaz, I. Bayram, F. Erbey, A. Tanyeli. Can any mass or cerebral hematoma be the leukemia? chloroma Nobel Medicus. 2012; 8(2): 118-120.

13. S. Yilmaz, N. Inandiklioglu, D. Yildizdas, C. Subasi, A. Acikalin, Y. Kuyucu, I. Bayram, A. Topak, A. Tanyeli, Duruksu G, Karaoz E. Mesenchymal Stem Cell: Does it Work in an Experimental Model with Acute Respiratory Distress Syndrome? Stem Cell Rev 2013; 19(1):80-92. DOI: 10.1007/s12015-012-9395-2

14. N. Inandiklioglu, S. Yilmaz, O. Demirhan, S. Erdogan, A. Tanyeli. Chromosome imbalances and alterations of AURKA and MYCN genes in children with neuroblastoma. Asian Pac J Cancer Prev 2012;13(11):5391-5397.

15. S. Yilmaz, D. Yildizdas, K. Daglioglu, A. Acikalin, C. Acipayam, I. Bayram, D. Gumurdulu, A. Tanyeli. The effects of salbutamol in an experimental model with Acut Respiratory Distress Syndrome. J Acute D, 2012; 1(2): 94-99. DOI: 10.1016/S2221-6189(13)60066-9.

16. S. Yilmaz, K. Daglioglu, D. Yildizdas, I. Bayram, K. Erdogan, D. Gumurdulu, S. Polat. The effect of heliox in Acute Respiratory Distress Syndrome. Ann Thorac Med, 2013; 8(1): 46-52. DOI: 10.4103/1817-1737.105719.

17. M. Elli, S. Yilmaz, R. Aydin, S. Murat, M.C. Bilgici, A. Dagdemir. Rituximab used in three cases with non-Hodgkin's lymphoma. Mol Clin Onco 2013; 1:550-552. DOI: 10.3892/mco.2013.88

18. S. Yilmaz, D. Yildizdas, C. Acipayam, I. Bayram, N. Ozcan, O.O. Horoz, A. Tanyeli. The effect of thrombocytopenia on outcome in critically ill children. Crit Care Shock 2013; 16 (2): 48-57.

19. S. Yilmaz, C. Acipayam, F. Erbey, G. Sezgin, I. Bayram, Y. Tuccar, N. Inandiklioglu, A. Tanyeli. Behavior of sphingosine 1-phosphate receptor 4 gene expression in patients with neuroblastoma. Int J Hemato Oncology 2013; 23(2):88-96. DOI: 10.4999/uhod.12019

20. Acipayam C, Bayram I, Daglioglu K, Doran F, Yilmaz S, Sezgin G, Totan Ateş B, Ozkan A, Tanyeli A. The protective effect of hesperidin on methotrexate-induced intestinal epithelial damage in rats: an experimental study. Med Prince Pract. 2014; 23(1):45-52. doi: 10.1159/000355900.

21. Acipayam C, Sezgin G, Bayram I, Yılmaz S, Ozkan A, Tuncel DA, Tanyeli A, Kupeli S. Treatment of Wilms tumor using carboplatin compared to therapy without carboplatin. Pediatric Blood Cancer. 2014 Apr 11. doi: 10.1002/pbc.25047.

22. Yavuz S, Anarat A, Bayazıt AK, Karagun BŞ, Yilmaz S, Kılınc Y, Gonlusen G, Kuyucu Y. Membranous nephropathy pre

senting with nephrotic syndrome in a child with thalassemia major. Pediatric Int. 2015 Feb 24. doi: 10.1111/ped.12572. [Epub ahead of print]

23. Yilmaz S, Yildizdas RD, Dursun O, Karapinar B, Kendirli T, Demirkol D, Citak A, Kupesiz A, Tekguc H, Duyu M, Yazici P, Yukselmis U, Odek C, Yaman A, Bayraktar S, Şık G, Cakir FB. Noninvasive ventilation in cancer children with acute respiratory failure. J Acute Dis 2017; 6(1):23-27.

24. Yilmaz S, Kuskucu A, Horoz OO, Suakar O, Imamova N, Gongor G, Yildizdas D. Polymorphism of hypoxia-inducible factor-1α gene in pediatric acute respiratory distress syndrome. J Acute Dis 2019; 8(2): 67-71.

  25. Mohammed EE, Yilmaz S, Alagoz Akcin O, Nalbantoglu B, Ficicioglu C, Fikrettin Sahin, Aydemir E.Cumulus cell: Is a new candidate for cell therapy? in vivo. 2019. 33: 1921-1927.

26. Rubab Z, Yilmaz S. Is tRNA driving breast cancer progression? Pakistan J Medicine Dent. 2019; 8(4): 63-65.

27. Yilmaz S, Yoruk A, Zemheri IE, Kuskucu A, Suakar O, Imamova N, Canizci P. Hypoxia Inducible Factor-1 alpha (Hif-1 alpha) Polymorphism in Lymphoma and Reactive Lymphoid Hyperplasia. Asian Pac J Cancer Biol. 2019; 4 (2): 35-40.

28. Yilmaz S, Uzunoglu I, Inandiklioglu N, Cag Y, Karaaslan A, Cetin C, Akin Y. The evaluation of complete blood count ratios in children with 2019 novel coronavirus (2019‐ncov) infection. Medicine Science 2022;11(1):214-9.

29. Kiyar M, Ozkan B, Arslan KS, Yilmaz S. The Evaluation of Hematological Parameters in Newborn Diagnosed with Congenital Pneumonia. South Asian Res J App Med Sci. 2022; 4(4):25-30. DOI: 10.36346/sarjams.2022.v04i04.001

30. Burukcu D, Yilmaz S, Alagoz O, Yaltirik KC, Attar NE, Sahin F, Aydemir EC. The investigation of diverse physiological and therapeutic impact of cellular-based products derived from human cumulus cells. Turk J Biol 2022; in press

Articles published in national peer-reviewed journals:

1. M.Inalhan, S.Yilmaz, B.Sumer, S.Akarcay, A.U.Yilmaz, S.Inan. Medical Journal of Haydarpasa Numune Hospital, The investigation of 103 cases with Acute Glomerulonephritis at Zeynep Kamil Maternity and Children's Hospital in the last five years, 1996; 36:184-188.

2. O. Ceran, S. Yılmaz, B. Karadağ, T. Özkozacı, A. Bozaykut, S. İnan. Investigation of children hospitalized in Zeynep Kamil Women's and Children's Hospital in 1996. Zeynep Kamil Medical Bulletin 1997; 29(1): 121-122.

3. S. Yilmaz, A.U. Yilmaz, M. Akin, E. Sak, S. Inan. The relationship between first morning urine density and nocturnal urinary incontinence in children aged 3-6 years. Clinical Sciences & DOCTOR 1999; 3(5): 371-373.

4. S. Yilmaz, E. Soyucen. Esophageal atresia and tracheoesophageal fistula in the newborn: a case report. (The Journal of The Child) Children's Journal 2007; 7: 201-203.

5. F. Erbey, I. Bayram, S. Yilmaz, E. Ovali, A. Tanyeli. Mesenchymal Stem Cell Experience in Acute Graft Versus Host Disease Erciyes Medical Journal 2010; 32(2):151-152.

6. S. Yilmaz, K. Daglioglu, I. Bayram, C. Acipayam, G. Ucar, C. El, D.G. Anlar, B. Zorlugenc, F. Doran, A. Tanyeli. The effect of grape extract in rats with methotrexate induced intestinal mucositis. Turkiye Klinikleri Journal of Medical Science 2012;32(6):1660-1667.

7. S. Yilmaz, O.O. Horoz, S. Soyupak, F. Erbey, I. Bayram, D. Yildizdas. Interpretation of chest radiographs in both cancer and other critical care patients with acute respiratory distress syndrome. Cukurova Med J 2013; 38(2): 270-273.

8. Kartal V, Zara Z, Yilmaz S, Ayhan A, Yoruk A, Timur C. A thrombosis story and PRES. North Clin Istanbul 2014;1(1):49-52. doi: 10.14744/nci.2014.25744.

9. Acipayam C, Bayram I, Yilmaz S, Sezgin G, Ozkan A, Tanyeli A. The Effectiveness of Enteral Nutrition Support in the Growth of Children Patients with Cancer. JCAM. 2014; DOI: 10.4328/JCAM.2637

10. Turan T, Akay A, Kapar A, Yılmaz S. Investigation of C-Reactive protein level and neutrophil/lymphocyte ratio in children with viral upper respiratory tract infection. KSU Faculty of Medicine Course 2020; In print.

11. Yilmaz S, Horoz OO, Gungor G, Yildizdas D. ABO blood type and Pediatric Acute Respiratory Distress Syndrome. J Pediatr Emerg Intensive Care Med 2021;8(1):65-66.

12: Kapar A, Yılmaz S, Dibeklioğlu SE, Akay A, Turan T. The approach of pediatricians and specialists to meningococcal vaccines and the measurement of their knowledge levels. Troia Med J 2021; 2(3):90-96.



Chapters in international books:

Atila Tanyeli., 2012. Koç Clinical Case Solutions, Pediatric (J. Round, L. Stradling, A. Myers. Paediatrics: Clinical Cases Uncovered). In: Case 12, Ralph's inguinal mass. S. Yilmaz. Adana, Nobel (Willey-Blackwell), 64-66 pp.
Philip A. Pizzo, David G. Poplack. 2015. Principles and Practice of Pediatric Oncology. In: Rachel Rau, Mignon L. Loh. Myeloproliferative Neoplasms of Childhood. Yilmaz S, Tanyeli A. Lippincott Williams and Wilkins, Philadelphia, United States, 7th edition. 545-567 pp:
Chapters in national books:

S. Yilmaz, B. Tufan Tas. Cancer Agenda Journal, Childhood CNetwork Cancers. Cancer and Ethics.Vol: 4/1-2, January-April 2016, pp.267-271.
Cengiz Yakinci. Humanities in medicine. Written expression and Medicine. S. Yilmaz. İnönü University Press, Malatya, pp.255-261, 2022
Ergun Cil. Algorithms from finding to diagnosis in children. Western masses. S. Yilmaz. Istanbul Medical Bookstores. 2nd edition. 2022.

28 November - 2 December 2012
56th Turkish National Pediatrics Congress, Disease Stories Competition, 3rd prize
Kyrenia, TRNC

04 - 07 April 2013
1st prize with a verbal presentation of "Effects of mesenchymal stem cells in Acute Respiratory Distress Syndrome" presented at the X. National Emergency Medicine and Pediatric Intensive Care Congress
Antalya Turkey

Disease Stories Contest 3rd Prize

İhsan Doğramacı Publication Award. “Use of mesenchymal stem cells in acute respiratory distress syndrome”. Best essay contest, 3rd prize

Değerli Yorumlarınızı Bekliyoruz.